Health Condition 1: A499- Bacterial infection, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient of all age groups Patients on prolonged Hospitalization in Intensive Care Unit Patients on Ventilator Indwelling catheters Medical Surgical Orthopedic implants and suspected sepsis Patient with open injuries following accidents Patient with history of malignancy Patient with long term ulcers due to diabetes Mellitus
Exclusion criteria
Exclusion criteria: Other species of Acinetobacter other than Acinetobacter baumannii Patients already on Antibiotic therapy and those admitted for less than 48 hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To know The utility of phenotypic method and Genotypic Methods in detecting Carbapenem-resistance in Acinetobacter baumannii. Carbapenemase gene prevalence in Acinetobacterbaumannii. 2.To know the antibiotic resistance pattern of Carbapenem resistance in Acinetobacter baumannii in our area. This will help to institute appropriate empirical treatment. Timepoint: Assessments will be done at 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Datta Meghe Institute of Higher Education and Research